The Lactobacillus casei group: History and health related applications
dc.contributor.author | Hill, Daragh | |
dc.contributor.author | Sugrue, Ivan | |
dc.contributor.author | Tobin, Conor | |
dc.contributor.author | Hill, Colin | |
dc.contributor.author | Stanton, Catherine | |
dc.contributor.author | Ross, R. Paul | |
dc.contributor.funder | Science Foundation Ireland | en |
dc.contributor.funder | Teagasc | en |
dc.contributor.funder | Horizon 2020 | en |
dc.date.accessioned | 2019-11-25T20:13:43Z | |
dc.date.available | 2019-11-25T20:13:43Z | |
dc.date.issued | 2018-09-10 | |
dc.description.abstract | The Lactobacillus casei group, composed of the closely related Lactobacillus casei, Lactobacillus paracasei, and Lactobacillus rhamnosus are some of the most widely researched and applied probiotic species of lactobacilli. The three species have been extensively studied, classified and reclassified due to their health promoting properties. Differentiation is often difficult by conventional phenotypic and genotypic methods and therefore new methods are being continually developed to distinguish the three closely related species. The group remain of interest as probiotics, and their use is widespread in industry. Much research has focused in recent years on their application for health promotion in treatment or prevention of a number of diseases and disorders The Lactobacillus casei group have the potential to be used prophylactically or therapeutically in diseases associated with a disturbance to the gut microbiota. The group have been extensively researched with regard to stress responses, which are crucial for their survival and therefore application as probiotics. | en |
dc.description.sponsorship | Teagasc (Walsh Fellowships); Horizon 2020 (JPI Food Processing for Health funded ‘Longlife') | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Published Version | en |
dc.format.mimetype | application/pdf | en |
dc.identifier.articleid | 2107 | en |
dc.identifier.citation | Hill D., Sugrue I., Tobin C., Hill C., Stanton C. and Ross R. P. (2018) 'The Lactobacillus casei Group: History and Health Related Applications'. Frontiers in Microbiology, 9, 2107. (12pp.) doi: 10.3389/fmicb.2018.02107 | en |
dc.identifier.doi | 10.3389/fmicb.2018.02107 | en |
dc.identifier.eissn | 1664-302X | |
dc.identifier.endpage | 12 | en |
dc.identifier.journaltitle | Frontiers in Microbiology | en |
dc.identifier.startpage | 1 | en |
dc.identifier.uri | https://hdl.handle.net/10468/9218 | |
dc.identifier.volume | 9 | en |
dc.language.iso | en | en |
dc.publisher | Frontiers Media | en |
dc.relation.project | info:eu-repo/grantAgreement/SFI/SFI Research Centres/12/RC/2273/IE/Alimentary Pharmabiotic Centre (APC) - Interfacing Food & Medicine/ | en |
dc.relation.project | info:eu-repo/grantAgreement/EC/H2020::CSA/696300/EU/The second coordination and support action for the JPI Healthy Diet for a Healthy Life/CSA JPI HDHL 2.0 | en |
dc.relation.uri | https://www.frontiersin.org/articles/10.3389/fmicb.2018.02107 | |
dc.rights | © 2018 Hill, Sugrue, Tobin, Hill, Stanton and Ross. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. | en |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en |
dc.subject | Lactobacillus | en |
dc.subject | Casei | en |
dc.subject | Paracasei | en |
dc.subject | Rhamnosus | en |
dc.subject | Taxonomy | en |
dc.subject | Health promotion | en |
dc.subject | Stress responses | en |
dc.title | The Lactobacillus casei group: History and health related applications | en |
dc.type | Article (peer-reviewed) | en |